Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

Thierry Artzner, William Bernal, Luca S. Belli, Sara Conti, Paolo A. Cortesi, Sophie‐Caroline Sacleux, George‐Philippe Pageaux, Sylvie Radenne, Jonel Trebicka, Javier Fernandez, Giovanni Perricone, Salvatore Piano, Silvio Nadalin, Maria C. Morelli, Silvia Martini, Wojciech G. Polak, Krzysztof Zieniewicz, Christian Toso, Marina Berenguer, Claudia Iegri, Federica Invernizzi, Riccardo Volpes, Vincent Karam, René Adam, François Faitot, Liane Rabinowich, Faouzi Saliba, Lucy Meunier, Mickael Lesurtel, Frank E.

Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome

Laura Napoleone, Cristina Solé, Adrià Juanola, Ann T. Ma, Marta Carol, Martina Pérez‐Guasch, Ana‐Belén Rubio, Marta Cervera, Emma Avitabile, Octavi Bassegoda, Jordi Gratacós‐Ginès, Manuel Morales‐Ruiz, Núria Fabrellas, Isabel Graupera, Elisa Pose, Gonzalo Crespo, Elsa Solà, Pere Ginès – 9 May 2022 – Impairment of kidney function is common in acute‐on‐chronic liver failure (ACLF). Patterns of kidney dysfunction and their impact on kidney and patient outcomes are ill‐defined.

Abnormal liver tests are not sufficient for diagnosis of hepatic graft‐versus‐host disease in critically ill patients

Alexander H. Yang, Mai Ai Thanda Han, Niharika Samala, Bisharah S. Rizvi, Rachel Marchalik, Ohad Etzion, Elizabeth C. Wright, Ruchi Patel, Vinshi Khan, Devika Kapuria, Vikramaditya Samala Venkat, David E. Kleiner, Christopher Koh, Jennifer A. Kanakry, Christopher G. Kanakry, Steven Pavletic, Kirsten M. Williams, Theo Heller – 8 May 2022 – Hepatic graft‐versus‐host disease (HGVHD) contributes significantly to morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Clinical findings and liver biomarkers are neither sensitive nor specific.

Subscribe to